Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 10.47
(4.7%)
CNY 10.47
(4.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.52 Billion CNY | -3.36% |
| 2022 | -3.41 Billion CNY | -9.06% |
| 2021 | -3.12 Billion CNY | -62.77% |
| 2020 | -1.92 Billion CNY | 19.3% |
| 2019 | -2.38 Billion CNY | -0.08% |
| 2018 | -2.37 Billion CNY | -145.99% |
| 2017 | -967.22 Million CNY | -53.48% |
| 2016 | -630.18 Million CNY | -168.03% |
| 2015 | 926.35 Million CNY | -35.78% |
| 2014 | 1.44 Billion CNY | 55.84% |
| 2013 | 925.64 Million CNY | 204.82% |
| 2012 | -883.08 Million CNY | 54.49% |
| 2011 | -1.94 Billion CNY | 7.94% |
| 2010 | -2.1 Billion CNY | -6343.39% |
| 2009 | 33.75 Million CNY | 14.74% |
| 2008 | 29.42 Million CNY | 15.0% |
| 2007 | 25.58 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.57 Billion CNY | 21.3% |
| 2024 Q3 | -2.95 Billion CNY | -14.09% |
| 2024 Q1 | -3.27 Billion CNY | 7.11% |
| 2023 Q4 | -3.52 Billion CNY | 0.21% |
| 2023 Q1 | -3.35 Billion CNY | 1.78% |
| 2023 FY | -3.52 Billion CNY | -3.36% |
| 2023 Q2 | -3.35 Billion CNY | -0.26% |
| 2023 Q3 | -3.53 Billion CNY | -5.18% |
| 2022 FY | -3.41 Billion CNY | -9.06% |
| 2022 Q1 | -3.48 Billion CNY | -11.32% |
| 2022 Q2 | -3.33 Billion CNY | 4.17% |
| 2022 Q3 | -3.17 Billion CNY | 4.84% |
| 2022 Q4 | -3.41 Billion CNY | -7.43% |
| 2021 Q2 | -2.02 Billion CNY | 5.9% |
| 2021 FY | -3.12 Billion CNY | -62.77% |
| 2021 Q1 | -2.14 Billion CNY | -11.86% |
| 2021 Q4 | -3.12 Billion CNY | -36.5% |
| 2021 Q3 | -2.29 Billion CNY | -13.28% |
| 2020 FY | -1.92 Billion CNY | 19.3% |
| 2020 Q4 | -1.92 Billion CNY | 2.09% |
| 2020 Q3 | -1.96 Billion CNY | -2.95% |
| 2020 Q1 | -2.12 Billion CNY | 10.55% |
| 2020 Q2 | -1.9 Billion CNY | 10.49% |
| 2019 Q2 | -2.08 Billion CNY | 3.55% |
| 2019 Q1 | -2.16 Billion CNY | 9.14% |
| 2019 FY | -2.38 Billion CNY | -0.08% |
| 2019 Q3 | -2.04 Billion CNY | 2.16% |
| 2019 Q4 | -2.38 Billion CNY | -16.72% |
| 2018 Q4 | -2.37 Billion CNY | -18.35% |
| 2018 FY | -2.37 Billion CNY | -145.99% |
| 2018 Q3 | -2.01 Billion CNY | -57.42% |
| 2018 Q2 | -1.27 Billion CNY | -9.03% |
| 2018 Q1 | -1.17 Billion CNY | -21.1% |
| 2017 Q1 | -525.04 Million CNY | 16.68% |
| 2017 FY | -967.22 Million CNY | -53.48% |
| 2017 Q4 | -967.22 Million CNY | -97.78% |
| 2017 Q3 | -489.04 Million CNY | 13.69% |
| 2017 Q2 | -566.61 Million CNY | -7.92% |
| 2016 Q2 | 188.63 Million CNY | -41.64% |
| 2016 Q1 | 323.23 Million CNY | -65.11% |
| 2016 FY | -630.18 Million CNY | -168.03% |
| 2016 Q4 | -630.18 Million CNY | -297.82% |
| 2016 Q3 | 318.56 Million CNY | 68.88% |
| 2015 FY | 926.35 Million CNY | -35.78% |
| 2015 Q3 | 1.01 Billion CNY | -27.68% |
| 2015 Q2 | 1.39 Billion CNY | -6.06% |
| 2015 Q4 | 926.35 Million CNY | -8.45% |
| 2015 Q1 | 1.48 Billion CNY | 3.26% |
| 2014 Q1 | 1.31 Billion CNY | 41.83% |
| 2014 Q4 | 1.44 Billion CNY | -12.04% |
| 2014 FY | 1.44 Billion CNY | 55.84% |
| 2014 Q2 | 1.52 Billion CNY | 16.32% |
| 2014 Q3 | 1.64 Billion CNY | 7.4% |
| 2013 FY | 925.64 Million CNY | 204.82% |
| 2013 Q4 | 925.64 Million CNY | 110.63% |
| 2013 Q3 | 439.47 Million CNY | 455.51% |
| 2013 Q2 | -123.61 Million CNY | 78.53% |
| 2013 Q1 | -575.81 Million CNY | 34.8% |
| 2012 Q3 | -1.42 Billion CNY | 20.32% |
| 2012 FY | -883.08 Million CNY | 54.49% |
| 2012 Q4 | -883.08 Million CNY | 37.87% |
| 2012 Q1 | -1.88 Billion CNY | 2.98% |
| 2012 Q2 | -1.78 Billion CNY | 5.24% |
| 2011 Q3 | -1.89 Billion CNY | 6.14% |
| 2011 Q2 | -2.01 Billion CNY | -0.07% |
| 2011 Q1 | -2.01 Billion CNY | 4.36% |
| 2011 Q4 | -1.94 Billion CNY | -2.48% |
| 2011 FY | -1.94 Billion CNY | 7.94% |
| 2010 Q2 | 110.3 Million CNY | 0.0% |
| 2010 Q4 | -2.1 Billion CNY | -1714.36% |
| 2010 FY | -2.1 Billion CNY | -6343.39% |
| 2010 Q3 | 130.56 Million CNY | 18.37% |
| 2009 FY | 33.75 Million CNY | 14.74% |
| 2008 FY | 29.42 Million CNY | 15.0% |
| 2007 FY | 25.58 Million CNY | 0.0% |